PlexBio Co., Ltd.
PlexBio is pleased to recognize that Dr. Nicla Borrelli from the University "G. D'Annunzio", Chieti, Italy, will be presenting at 6th International Molecular Diagnostics Europe conference at Lisbon Portugal, from May 22-24, 2018 on results from studies using PlexBio’s IntelliPlex™ multiplexing technology.
Dr. Nicla Borrelli will be presenting on behalf of Dr. Antonio Marchetti, Professor of Pathology and Director of the Center of Predictive Molecular Medicine at the University "G. D'Annunzio", on his team’s collaborative research results on the “PlexBio molecular diagnostic system in the characterization and management of oncogene-addicted NSCLC patients” at the Enabling Technologies for Cell-Free DNA track.
Dr. Antonio Marchetti is well-known for his research on liquid biopsy in lung cancer and will be sharing his future perspective on multiplexing technology in using PlexBio Diagnostic platform.
In addition to Dr. Antonio Marchetti’s presentation, Dr. Stuart M. Palmer, PlexBio’s Chief Operating Officer, will also be presenting on the topic of “Multiplex Assays for Cancer Management Using πCode MicroDisc Technology” at the Circulating Tumor Cells track.
PlexBio has developed the πCode™ MicroDisc technology and IntelliPlex™ system as tools for building assays which enable the capture and detection of multiple targets from a complex sample simultaneously in a single reaction well.